MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pessah, I. N.
Right arrow Articles by Zimanyi, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pessah, I. N.
Right arrow Articles by Zimanyi, I.

Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action

IN Pessah and I Zimanyi

Department of Veterinary Pharmacology and Toxicology, University of California, Davis 95616.

Kinetic and equilibrium measurements of [3H]ryanodine binding to the Ca2+ release channel of rabbit skeletal and rat cardiac sarcoplasmic reticulum (SR) are examined to ascertain the nature of cooperative interactions among high and low affinity binding sites and to quantitate their distribution. Equilibrium studies reveal affinities of 1-4 nM for the highest affinity binding site and of 30-50 nM, 500-800 nM, and 2-4 microM for the lower affinity sites in both preparations, with Hill coefficients of significantly less than 1, and initial rates of association and dissociation increase with increasing concentrations of ryanodine. SR vesicles are actively loaded in the presence of pyrophosphate, and fluctuations in extravesicular Ca2+ are measured by the absorbance change of antipyrylazo III. The data demonstrate a biphasic, time- and concentration-dependent action of ryanodine on the release of Ca2+, with an initial activation and a subsequent inactivation phase. Kinetic analysis of the activation of Ca2+ release by ryanodine, in consonance with the binding data, demonstrates the existence of multiple binding sites for the alkaloid on the channel complex, with nanomolar to micromolar affinities. Based on the present findings obtained by receptor binding analysis and Ca2+ transport measurements, we suggest a model that describes four, most plausibly negatively cooperative, binding sites on the Ca2+ release channel. Occupation of ryanodine binding sites produces sequential activation followed by inactivation of the SR channel, revealing the strong possibility of an irreversible uncoupling of the native function of the receptor/channel complex by high concentrations of ryanodine. A model relating ryanodine receptor occupancy with SR Ca2+ release stresses two important new findings regarding the interaction of ryanodine with its receptor. First, ryanodine binds to four sites on the oligomeric channel complex with decreasing affinities, which can be best described by allosteric negative cooperativity. Second, binding of ryanodine to its receptor activates the Ca2+ release channel in a concentration- dependent and saturable manner in the range of 20 nM to 1 mM and produces a kinetically limited and sequential inactivation of the Ca2+ channel, with the concomitant attainment of full negative cooperativity. The results presented suggest that driving of the complex toward full negative cooperativity with high concentrations of ryanodine promotes a long-lived conformational state in which ryanodine is physically occluded and hindered from free diffusion from its binding site.

Volume 39, Issue 5, pp. 679-689, 05/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. Cherednichenko, C. W. Ward, W. Feng, E. Cabrales, L. Michaelson, M. Samso, J. R. Lopez, P. D. Allen, and I. N. Pessah
Enhanced Excitation-Coupled Calcium Entry in Myotubes Expressing Malignant Hyperthermia Mutation R163C Is Attenuated by Dantrolene
Mol. Pharmacol., April 1, 2008; 73(4): 1203 - 1212.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
O. Ostrovskaya, R. Goyal, N. Osman, C. E. McAllister, I. N. Pessah, J. R. Hume, and S. M. Wilson
Inhibition of Ryanodine Receptors by 4-(2-Aminopropyl)-3,5-dichloro-N,N-dimethylaniline (FLA 365) in Canine Pulmonary Arterial Smooth Muscle Cells
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 381 - 390.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Yang, E. Esteve, I. N. Pessah, T. F. Molinski, P. D. Allen, and J. R. Lopez
Elevated resting [Ca2+]i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1591 - C1598.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. MacMillan, S. Chalmers, T. C. Muir, and J. G. McCarron
IP3-mediated Ca2+ increases do not involve the ryanodine receptor, but ryanodine receptor antagonists reduce IP3-mediated Ca2+ increases in guinea-pig colonic smooth muscle cells
J. Physiol., December 1, 2005; 569(2): 533 - 544.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Laporte, A. Hui, and I. Laher
Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle
Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Cherednichenko, A. M. Hurne, J. D. Fessenden, E. H. Lee, P. D. Allen, K. G. Beam, and I. N. Pessah
Conformational activation of Ca2+ entry by depolarization of skeletal myotubes
PNAS, November 2, 2004; 101(44): 15793 - 15798.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Paolini, J. D. Fessenden, I. N. Pessah, and C. Franzini-Armstrong
Evidence for conformational coupling between two calcium channels
PNAS, August 24, 2004; 101(34): 12748 - 12752.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
C. S. Hui, H. R. Besch Jr., and K. R. Bidasee
Effects of Ryanoids on Spontaneous and Depolarization-Evoked Calcium Release Events in Frog Muscle
Biophys. J., July 1, 2004; 87(1): 243 - 255.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Gafni, P. W. Wong, and I. N. Pessah
Non-coplanar 2,2',3,5',6-Pentachlorobiphenyl (PCB 95) Amplifies Ionotropic Glutamate Receptor Signaling in Embryonic Cerebellar Granule Neurons by a Mechanism Involving Ryanodine Receptors
Toxicol. Sci., January 1, 2004; 77(1): 72 - 82.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Wang, L. Zhang, J. Bolstad, N. Diao, C. Brown, L. Ruest, W. Welch, A. J. Williams, and S. R. W. Chen
Residue Gln4863 within a Predicted Transmembrane Sequence of the Ca2+ Release Channel (Ryanodine Receptor) Is Critical for Ryanodine Interaction
J. Biol. Chem., December 19, 2003; 278(51): 51557 - 51565.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Aracena, G. Sanchez, P. Donoso, S. L. Hamilton, and C. Hidalgo
S-Glutathionylation Decreases Mg2+ Inhibition and S-Nitrosylation Enhances Ca2+ Activation of RyR1 Channels
J. Biol. Chem., October 31, 2003; 278(44): 42927 - 42935.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yang, T. A. Ta, I. N. Pessah, and P. D. Allen
Functional Defects in Six Ryanodine Receptor Isoform-1 (RyR1) Mutations Associated with Malignant Hyperthermia and Their Impact on Skeletal Excitation-Contraction Coupling
J. Biol. Chem., July 3, 2003; 278(28): 25722 - 25730.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Fill and J. A. Copello
Ryanodine Receptor Calcium Release Channels
Physiol Rev, October 1, 2002; 82(4): 893 - 922.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. R. Bidasee, U. D. Dincer, and H. R. Besch Jr.
Ryanodine Receptor Dysfunction in Hearts of Streptozotocin-Induced Diabetic Rats
Mol. Pharmacol., December 1, 2001; 60(6): 1356 - 1364.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. G. Du, X. Guo, V. K. Khanna, and D. H. MacLennan
Ryanodine sensitizes the cardiac Ca2+ release channel (ryanodine receptor isoform 2) to Ca2+ activation and dissociates as the channel is closed by Ca2+ depletion
PNAS, October 31, 2001; (2001) 241516898.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Masumiya, P. Li, L. Zhang, and S. R. W. Chen
Ryanodine Sensitizes the Ca2+ Release Channel (Ryanodine Receptor) to Ca2+ Activation
J. Biol. Chem., October 19, 2001; 276(43): 39727 - 39735.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I. N. Pessah, C. Beltzner, S. W. Burchiel, G. Sridhar, T. Penning, and W. Feng
A Bioactive Metabolite of Benzo[a]pyrene, Benzo[a]pyrene-7,8-dione, Selectively Alters Microsomal Ca2+ Transport and Ryanodine Receptor Function
Mol. Pharmacol., March 1, 2001; 59(3): 506 - 513.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Fessenden, L. Chen, Y. Wang, C. Paolini, C. Franzini-Armstrong, P. D. Allen, and I. N. Pessah
Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine
PNAS, February 8, 2001; (2001) 41608898.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. H. Jaggar, V. A. Porter, W. J. Lederer, and M. T. Nelson
Calcium sparks in smooth muscle
Am J Physiol Cell Physiol, February 1, 2000; 278(2): C235 - C256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chen, T. F. Molinski, and I. N. Pessah
Bastadin 10 Stabilizes the Open Conformation of the Ryanodine-sensitive Ca2+ Channel in an FKBP12-dependent Manner
J. Biol. Chem., November 12, 1999; 274(46): 32603 - 32612.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. G. Du, J. P. Imredy, and D. H. MacLennan
Characterization of Recombinant Rabbit Cardiac and Skeletal Muscle Ca2+ Release Channels (Ryanodine Receptors) with a Novel [3H]Ryanodine Binding Assay
J. Biol. Chem., December 11, 1998; 273(50): 33259 - 33266.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Kawakami and E. Okabe
Superoxide Anion Radical-Triggered Ca2+ Release from Cardiac Sarcoplasmic Reticulum through Ryanodine Receptor Ca2+ Channel
Mol. Pharmacol., March 1, 1998; 53(3): 497 - 503.
[Abstract] [Full Text]


Home page
J. Cell Biol.Home page
R.A. Moore, H. Nguyen, J. Galceran, I.N. Pessah, and P.D. Allen
A Transgenic Myogenic Cell Line Lacking Ryanodine Receptor Protein for Homologous Expression Studies: Reconstitution of Ry1R Protein and Function
J. Cell Biol., February 23, 1998; 140(4): 843 - 851.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. T. Sudo and T. E. Nelson
Changes in Ryanodine-Induced Contractures by Stimulus Frequency in Malignant Hyperthermia Susceptible and Malignant Hyperthermia Nonsusceptible Dog Skeletal Muscle
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1331 - 1336.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
P. W. Wong, W. R. Brackney, and I. N. Pessah
ortho-Substituted Polychlorinated Biphenyls Alter Microsomal Calcium Transport by Direct Interaction with Ryanodine Receptors of Mammalian Brain
J. Biol. Chem., June 13, 1997; 272(24): 15145 - 15153.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Zucchi and S. Ronca-Testoni
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States
Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. L. Sutko, J. A. Airey, W. Welch, and L. Ruest
The Pharmacology of Ryanodine and Related Compounds
Pharmacol. Rev., March 1, 1997; 49(1): 53 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Sierralta, M. Fill, and B. A. Suarez-Isla
Functionally Heterogenous Ryanodine Receptors in Avian Cerebellum
J. Biol. Chem., July 19, 1996; 271(29): 17028 - 17034.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Wang, D. H. Needleman, A. B. Seryshev, B. Aghdasi, K. J. Slavik, S.-Q. Liu, S. E. Pedersen, and S. L. Hamilton
Interaction between Ryanodine and Neomycin Binding Sites on Ca[IMAGE] Release Channel from Skeletal Muscle Sarcoplasmic Reticulum
J. Biol. Chem., April 5, 1996; 271(14): 8387 - 8393.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H Cheng, W. Lederer, and M. Cannell
Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle
Science, October 29, 1993; 262(5134): 740 - 744.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Fessenden, L. Chen, Y. Wang, C. Paolini, C. Franzini-Armstrong, P. D. Allen, and I. N. Pessah
Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine
PNAS, February 27, 2001; 98(5): 2865 - 2870.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. G. Du, X. Guo, V. K. Khanna, and D. H. MacLennan
Ryanodine sensitizes the cardiac Ca2+ release channel (ryanodine receptor isoform 2) to Ca2+ activation and dissociates as the channel is closed by Ca2+ depletion
PNAS, November 20, 2001; 98(24): 13625 - 13630.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics